SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 55.298
AS - Asia 27.712
EU - Europa 21.899
SA - Sud America 4.573
Continente sconosciuto - Info sul continente non disponibili 1.017
AF - Africa 606
OC - Oceania 80
AN - Antartide 2
Totale 111.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 54.103
SG - Singapore 10.392
FI - Finlandia 6.703
CN - Cina 6.660
IT - Italia 4.660
BR - Brasile 3.503
VN - Vietnam 2.739
UA - Ucraina 2.509
HK - Hong Kong 2.441
DE - Germania 2.166
TR - Turchia 1.624
GB - Regno Unito 1.474
BD - Bangladesh 975
FR - Francia 967
SE - Svezia 816
RU - Federazione Russa 726
PL - Polonia 665
JP - Giappone 633
IN - India 549
CA - Canada 533
MX - Messico 422
ID - Indonesia 356
AR - Argentina 354
NL - Olanda 237
IQ - Iraq 220
ZA - Sudafrica 198
EC - Ecuador 183
ES - Italia 178
CO - Colombia 174
PK - Pakistan 167
BE - Belgio 123
VE - Venezuela 115
AT - Austria 110
PH - Filippine 101
MY - Malesia 98
SA - Arabia Saudita 95
UZ - Uzbekistan 92
MA - Marocco 86
CL - Cile 78
LT - Lituania 72
CZ - Repubblica Ceca 71
IE - Irlanda 69
EG - Egitto 66
PY - Paraguay 66
AU - Australia 63
AE - Emirati Arabi Uniti 60
CH - Svizzera 57
JM - Giamaica 56
TN - Tunisia 55
KE - Kenya 53
KR - Corea 52
JO - Giordania 42
PE - Perù 41
UY - Uruguay 33
TH - Thailandia 32
AL - Albania 29
CR - Costa Rica 29
IL - Israele 29
OM - Oman 29
RO - Romania 28
DZ - Algeria 27
KZ - Kazakistan 27
TW - Taiwan 27
ET - Etiopia 25
GT - Guatemala 24
IR - Iran 24
NP - Nepal 23
AZ - Azerbaigian 22
BG - Bulgaria 22
GR - Grecia 22
HN - Honduras 22
LK - Sri Lanka 22
PT - Portogallo 22
SN - Senegal 22
LB - Libano 21
RS - Serbia 21
GE - Georgia 20
HU - Ungheria 20
TT - Trinidad e Tobago 20
HR - Croazia 18
KG - Kirghizistan 18
PS - Palestinian Territory 18
BO - Bolivia 16
NO - Norvegia 16
NZ - Nuova Zelanda 16
DO - Repubblica Dominicana 14
NI - Nicaragua 14
SV - El Salvador 14
BA - Bosnia-Erzegovina 13
BH - Bahrain 13
KW - Kuwait 13
EU - Europa 12
MD - Moldavia 12
PA - Panama 12
AM - Armenia 10
BY - Bielorussia 10
CI - Costa d'Avorio 10
DK - Danimarca 10
SY - Repubblica araba siriana 10
XK - ???statistics.table.value.countryCode.XK??? 10
Totale 109.969
Salva come PNG Salva come JPEG
Città #
Singapore 6.427
Helsinki 6.053
Ashburn 5.981
Fairfield 5.339
Woodbridge 5.002
Houston 3.209
Jacksonville 2.716
San Jose 2.605
Hong Kong 2.394
Chandler 2.390
Seattle 2.135
Ann Arbor 2.106
Santa Clara 1.915
Wilmington 1.879
Beijing 1.824
Cambridge 1.777
Dallas 1.717
Izmir 960
Ho Chi Minh City 896
Nanjing 872
New York 771
Princeton 751
Los Angeles 711
Council Bluffs 705
Warsaw 624
Hanoi 615
Tokyo 589
Lauterbourg 550
San Diego 481
Milan 478
Boardman 463
Munich 431
Ferrara 426
São Paulo 327
Shanghai 291
Rome 273
Mexico City 272
Shenyang 264
Nanchang 245
Jakarta 234
Chicago 222
Moscow 219
London 209
Toronto 170
Hefei 169
Tianjin 169
Buffalo 157
Changsha 156
Falls Church 155
Orem 152
Hebei 147
Jiaxing 147
Bologna 143
Turku 139
Bremen 136
Redwood City 132
Montreal 123
Rio de Janeiro 122
San Mateo 122
The Dalles 122
Brooklyn 121
Mountain View 119
Dong Ket 118
Phoenix 116
Brussels 115
Naples 114
Chennai 112
Frankfurt am Main 108
Addison 107
Da Nang 104
Haiphong 103
Johannesburg 103
Jinan 101
Atlanta 93
Nuremberg 93
Zhengzhou 93
San Francisco 92
Tashkent 86
Stockholm 85
Norwalk 82
Columbus 81
Dearborn 81
Baghdad 80
Guangzhou 79
Washington 78
Boston 77
Denver 77
Verona 76
Falkenstein 75
Manchester 74
Philadelphia 72
Quito 68
Belo Horizonte 67
Ningbo 65
Amsterdam 64
Kunming 64
Curitiba 61
Mumbai 59
Des Moines 57
Brasília 56
Totale 74.285
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 2.954
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 2.140
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.061
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.848
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 551
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 436
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 432
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 431
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 405
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 381
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 380
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 375
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 363
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 341
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 339
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 329
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 313
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 311
Poor response to clopidogrel: current and future options for its management 307
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 305
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 286
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 284
Cardiac resynchronization therapy guided by multimodality cardiac imaging 280
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 280
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study 273
2013 ESH/ESC Guidelines for the management of arterial hypertension 272
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 271
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 271
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 271
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 267
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 266
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 265
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 265
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 264
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 262
The role of Notch pathway in cardiovascular diseases. 260
Uric acid and coronary artery disease: An elusive link deserving further attention 258
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 258
Reperfusion Damage - A Story of Success, Failure, and Hope 254
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 252
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 252
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 251
2013 ESC guidelines on the management of stable coronary artery disease 250
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 249
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 248
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 248
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 247
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 247
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry 246
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 244
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 244
Aortic valve stenosis and mitochondrial dysfunctions: Clinical and molecular perspectives 243
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 242
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 242
KRIT1 deficiency promotes aortic endothelial dysfunction 242
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 242
ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: Diagnostic-therapeutic pathway in Italy 239
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 238
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 238
2013 ESH/ESC Guidelines for the management of arterial hypertension 238
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 237
Efficacy and safety of catheter ablation of atrioventricular nodal re-entrant tachycardia by means of flexible-tip irrigated catheters 236
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 235
Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy 233
Attualità e nuove prospettive in tema di cardiogenetica 232
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 232
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 229
Angina and left ventricular dysfunction: can we "reduce' it? 228
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 227
181 QUESTIONS & ANSWERS IN HEART FAILURE Heart failure 181 Questions & Answers. 227
Heart failure with preserved ejection fraction: uncertainties and dilemmas 227
Current views on anthracycline cardiotoxicity 227
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 224
Anti-anginal drugs: Systematic review and clinical implications 224
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 224
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 222
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 221
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry 221
Can we improve myocardial protection during ischaemic injury? 221
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 219
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 218
Current role of echocardiography in cardiac resynchronization therapy 218
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 218
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 215
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 214
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 211
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 210
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 210
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 210
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 210
99mTc-sestamibi gted -Spect evaluation of post stress left ventricular ejection fraction and volumes in hypertensive patients exhibiting a normal scintigraphic perfusion pattern 209
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 209
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 209
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 209
Prognosis after pacemaker implantation in extreme elderly 209
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 208
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry 208
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 208
From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure 208
Remote monitoring of implantable devices: Should we continue to ignore it? 207
Totale 34.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 486.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.498
Totale 493.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.747 0 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/202512.621 303 307 1.107 466 1.429 1.036 462 840 2.357 1.378 1.541 1.395
2025/202642.642 3.125 1.753 4.140 4.576 4.727 2.266 3.572 2.131 9.331 4.023 1.894 1.104
2026/20272.190 1.211 979 0 0 0 0 0 0 0 0 0 0
Totale 111.187